US 8492338
Targeted therapeutic proteins
granted A61KA61K38/30A61K38/47
Quick answer
US patent 8492338 (Targeted therapeutic proteins) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOMARIN PHARMACEUTICAL INC.
- Grant date
- Tue Jul 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K38/30, A61K38/47, A61K47/551, A61K47/6425